rectal cancer, rectal neuroendocrine tumor rectal cancer, rectal neuroendocrine tumor, surgery, anti-adhesion barrier
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.The patient must be at least 18 years of age at the time of enrollment. 2.The patient diagnosed with rectal cancer (including NET). 3.Patients scheduled for laparoscopic perineal rectal resection (including robot-assisted surgery). 4.The patient fully understand the study. 5.The patient has been fully informed of the contents of the study and has given written consent.
Exclusion criteria
Exclusion criteria: 1.The Patient with a history of transperitoneal surgery for pelvic organs. 2.The patient who are scheduled to undergo a combined resection of other organs. 3.The patient with pelvic infection. 4.The patient with a history of hypersensitivity to substances derived from corn starch. 5.The patient with glycogen storage disease. 6.The patient who is pregnant, may become pregnant, or wishes to become pregnant during the treatment period. 7.Any other patient who is judged by the physician to be inappropriate as a subject of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of small bowel obstruction within 30 days after surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of small bowel obstruction (Clavien-Dindo classification Grade III or higher) within 30 days after surgery Incidence of surgery site infection within 30 days after surgery Drain culture results on postoperative day 1, day 3, and before evacuation Postoperative days until resumption of oral intake Postoperative hospital stay Incidence of small bowel obstruction within 5 years after surgery | — |
Contacts
Osaka University Hospital